Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editor's Note: Functional Roles of Src and Fgr in Ovarian Carcinoma.
Kim HS, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MMK, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, Sood AK. Kim HS, et al. Among authors: roh jw. Clin Cancer Res. 2021 Aug 1;27(15):4452. doi: 10.1158/1078-0432.CCR-21-2118. Clin Cancer Res. 2021. PMID: 34341057 No abstract available.
Functional roles of Src and Fgr in ovarian carcinoma.
Kim HS, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MM, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, Sood AK. Kim HS, et al. Among authors: roh jw. Clin Cancer Res. 2011 Apr 1;17(7):1713-21. doi: 10.1158/1078-0432.CCR-10-2081. Epub 2011 Feb 7. Clin Cancer Res. 2011. PMID: 21300758 Free PMC article.
Targeting SRC in mucinous ovarian carcinoma.
Matsuo K, Nishimura M, Bottsford-Miller JN, Huang J, Komurov K, Armaiz-Pena GN, Shahzad MM, Stone RL, Roh JW, Sanguino AM, Lu C, Im DD, Rosenshien NB, Sakakibara A, Nagano T, Yamasaki M, Enomoto T, Kimura T, Ram PT, Schmeler KM, Gallick GE, Wong KK, Frumovitz M, Sood AK. Matsuo K, et al. Among authors: roh jw. Clin Cancer Res. 2011 Aug 15;17(16):5367-78. doi: 10.1158/1078-0432.CCR-10-3176. Epub 2011 Jul 7. Clin Cancer Res. 2011. PMID: 21737505 Free PMC article.
Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma.
Matsuo K, Nishimura M, Bottsford-Miller JN, Huang J, Komurov K, Armaiz-Pena GN, Shahzad MMK, Stone RL, Roh JW, Sanguino AM, Lu C, Im DD, Rosenshien NB, Sakakibara A, Nagano T, Yamasaki M, Enomoto T, Kimura T, Ram PT, Schmeler KM, Gallick GE, Wong KK, Frumovitz M, Sood AK. Matsuo K, et al. Among authors: roh jw. Clin Cancer Res. 2021 Aug 1;27(15):4450. doi: 10.1158/1078-0432.CCR-21-2116. Clin Cancer Res. 2021. PMID: 34341055 No abstract available.
Editor's Note: Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles.
Han HD, Mangala LS, Lee JW, Shahzad MMK, Kim HS, Shen D, Nam EJ, Mora EM, Stone RL, Lu C, Lee SJ, Roh JW, Nick AM, Lopez-Berestein G, Sood AK. Han HD, et al. Among authors: roh jw. Clin Cancer Res. 2021 Aug 1;27(15):4453. doi: 10.1158/1078-0432.CCR-21-2119. Clin Cancer Res. 2021. PMID: 34341058 No abstract available.
EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma.
Lee JW, Stone RL, Lee SJ, Nam EJ, Roh JW, Nick AM, Han HD, Shahzad MM, Kim HS, Mangala LS, Jennings NB, Mao S, Gooya J, Jackson D, Coleman RL, Sood AK. Lee JW, et al. Among authors: roh jw. Clin Cancer Res. 2010 May 1;16(9):2562-70. doi: 10.1158/1078-0432.CCR-10-0017. Epub 2010 Apr 13. Clin Cancer Res. 2010. PMID: 20388851 Free PMC article.
Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
Hu W, Lu C, Dong HH, Huang J, Shen DY, Stone RL, Nick AM, Shahzad MM, Mora E, Jennings NB, Lee SJ, Roh JW, Matsuo K, Nishimura M, Goodman BW, Jaffe RB, Langley RR, Deavers MT, Lopez-Berestein G, Coleman RL, Sood AK. Hu W, et al. Among authors: roh jw. Cancer Res. 2011 Sep 15;71(18):6030-9. doi: 10.1158/0008-5472.CAN-10-2719. Epub 2011 Jul 27. Cancer Res. 2011. PMID: 21795478 Free PMC article.
Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer.
Roh JW, Huang J, Hu W, Yang X, Jennings NB, Sehgal V, Sohn BH, Han HD, Lee SJ, Thanapprapasr D, Bottsford-Miller J, Zand B, Dalton HJ, Previs RA, Davis AN, Matsuo K, Lee JS, Ram P, Coleman RL, Sood AK. Roh JW, et al. Clin Cancer Res. 2021 Aug 1;27(15):4449. doi: 10.1158/1078-0432.CCR-21-2115. Clin Cancer Res. 2021. PMID: 34341054 No abstract available.
Targeted gene silencing using RGD-labeled chitosan nanoparticles.
Han HD, Mangala LS, Lee JW, Shahzad MM, Kim HS, Shen D, Nam EJ, Mora EM, Stone RL, Lu C, Lee SJ, Roh JW, Nick AM, Lopez-Berestein G, Sood AK. Han HD, et al. Among authors: roh jw. Clin Cancer Res. 2010 Aug 1;16(15):3910-22. doi: 10.1158/1078-0432.CCR-10-0005. Epub 2010 Jun 10. Clin Cancer Res. 2010. PMID: 20538762 Free PMC article.
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
Huang J, Hu W, Bottsford-Miller J, Liu T, Han HD, Zand B, Pradeep S, Roh JW, Thanapprapasr D, Dalton HJ, Pecot CV, Rupaimoole R, Lu C, Fellman B, Urbauer D, Kang Y, Jennings NB, Huang L, Deavers MT, Broaddus R, Coleman RL, Sood AK. Huang J, et al. Among authors: roh jw. Clin Cancer Res. 2014 Apr 1;20(7):1846-55. doi: 10.1158/1078-0432.CCR-13-2141. Epub 2014 Jan 31. Clin Cancer Res. 2014. PMID: 24486585 Free PMC article.
130 results